Advertisement

US approves 1st drug developed to prevent chronic migraines

May 19, 2018 04:05 PM

TRENTON, N.J. (AP) - U.S. regulators have approved the first drug designed to prevent chronic migraines.

Thursday's action by the Food and Drug Administration clears the monthly shot for sale. Aimovig (AIM'-oh-vig) is the first in a new class of long-acting drugs for preventing migraines. Three other shots are expected to win approval by next year, and several pills are being tested.

Advertisement – Content Continues Below

Current prevention treatments include pills originally developed for epilepsy and other conditions and the wrinkle reducer Botox, but many patients abandon them because they don't help much or cause serious side effects.

Migraines can cause disabling symptoms: throbbing headaches, nausea and vomiting, and sensitivity to light and sound.

Credits

By LINDA A. JOHNSON

Copyright 2018 The Associated Press. All rights reserved.

Advertisement
Relay Media Amp
Advertisement
Advertisement
Monument added to Guenette veteran apartments

Trump says US team in NKorea planning summit with Kim

Giuliani advises no Mueller interview without informant info

George H.W. Bush hospitalized in Maine

Budget battle brews as Trump threatens another shutdown

Advertisement